Gliosarcomas: Analysis of 11 cases do two subtypes exist?

Maurizio Salvati, Emanuela Caroli, Antonino Raco, Felice Giangaspero, Roberto Delfini, Luigi Ferrante

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

There are conflicting reports regarding gliosarcomas. The goal of this study is to examine clinical, radiological, surgical and therapeutic aspects of 11 patients with gliosarcoma. Between 1993 and 2001, 11 patients with cerebral gliosarcoma were treated at our Institute. Ten patients underwent surgery and one patient had stereotactic biopsy. Four patients received whole brain radiotherapy with 60Co, five underwent radiotherapy with LINAC extended 2 cm beyond the edema margins. One patient refused any additional treatment after surgery and one patient was not treated postoperatively for poor clinical conditions (KPS 40). Chemotherapy (temozolomide) was administered to four patients. Four patients had a prevalence of sarcomatous component that corresponded to surgical and radiological aspects similar to meningioma while six patients showed a prevalence of gliomatous component and radiological and surgical aspects similar to those of glioblastomas. Surgical resection was total in six and subtotal in four patients. Patients with prevalent sarcomatous component showed median survival time more prolonged than patients with prevalent gliomatous component (71 ± 6 weeks vs. 63 ± 6; P =0.0417). Moreover, the survival rate differed in relation to the therapy: patients treated with multimodality therapy (surgery, radiotherapy and chemotherapy) had a longer survival time than patients treated in single or bimodality. Despite prognosis of gliosarcomas remains poor, a multidisciplinary approach (surgery, radiotherapy and chemotherapy) seems to be associated with slight more prolonged survival times.

Original languageEnglish
Pages (from-to)59-63
Number of pages5
JournalJournal of Neuro-Oncology
Volume74
Issue number1
DOIs
Publication statusPublished - Aug 2005

Fingerprint

Gliosarcoma
Radiotherapy
temozolomide
Drug Therapy
Survival

Keywords

  • Chemotherapy
  • Gliosarcoma
  • Prognosis
  • Radiotherapy
  • Survival

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Cite this

Gliosarcomas : Analysis of 11 cases do two subtypes exist? / Salvati, Maurizio; Caroli, Emanuela; Raco, Antonino; Giangaspero, Felice; Delfini, Roberto; Ferrante, Luigi.

In: Journal of Neuro-Oncology, Vol. 74, No. 1, 08.2005, p. 59-63.

Research output: Contribution to journalArticle

Salvati, M, Caroli, E, Raco, A, Giangaspero, F, Delfini, R & Ferrante, L 2005, 'Gliosarcomas: Analysis of 11 cases do two subtypes exist?', Journal of Neuro-Oncology, vol. 74, no. 1, pp. 59-63. https://doi.org/10.1007/s11060-004-5949-8
Salvati, Maurizio ; Caroli, Emanuela ; Raco, Antonino ; Giangaspero, Felice ; Delfini, Roberto ; Ferrante, Luigi. / Gliosarcomas : Analysis of 11 cases do two subtypes exist?. In: Journal of Neuro-Oncology. 2005 ; Vol. 74, No. 1. pp. 59-63.
@article{a44439ef77a344dd99dd1712a3a9d2f6,
title = "Gliosarcomas: Analysis of 11 cases do two subtypes exist?",
abstract = "There are conflicting reports regarding gliosarcomas. The goal of this study is to examine clinical, radiological, surgical and therapeutic aspects of 11 patients with gliosarcoma. Between 1993 and 2001, 11 patients with cerebral gliosarcoma were treated at our Institute. Ten patients underwent surgery and one patient had stereotactic biopsy. Four patients received whole brain radiotherapy with 60Co, five underwent radiotherapy with LINAC extended 2 cm beyond the edema margins. One patient refused any additional treatment after surgery and one patient was not treated postoperatively for poor clinical conditions (KPS 40). Chemotherapy (temozolomide) was administered to four patients. Four patients had a prevalence of sarcomatous component that corresponded to surgical and radiological aspects similar to meningioma while six patients showed a prevalence of gliomatous component and radiological and surgical aspects similar to those of glioblastomas. Surgical resection was total in six and subtotal in four patients. Patients with prevalent sarcomatous component showed median survival time more prolonged than patients with prevalent gliomatous component (71 ± 6 weeks vs. 63 ± 6; P =0.0417). Moreover, the survival rate differed in relation to the therapy: patients treated with multimodality therapy (surgery, radiotherapy and chemotherapy) had a longer survival time than patients treated in single or bimodality. Despite prognosis of gliosarcomas remains poor, a multidisciplinary approach (surgery, radiotherapy and chemotherapy) seems to be associated with slight more prolonged survival times.",
keywords = "Chemotherapy, Gliosarcoma, Prognosis, Radiotherapy, Survival",
author = "Maurizio Salvati and Emanuela Caroli and Antonino Raco and Felice Giangaspero and Roberto Delfini and Luigi Ferrante",
year = "2005",
month = "8",
doi = "10.1007/s11060-004-5949-8",
language = "English",
volume = "74",
pages = "59--63",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Springer New York LLC",
number = "1",

}

TY - JOUR

T1 - Gliosarcomas

T2 - Analysis of 11 cases do two subtypes exist?

AU - Salvati, Maurizio

AU - Caroli, Emanuela

AU - Raco, Antonino

AU - Giangaspero, Felice

AU - Delfini, Roberto

AU - Ferrante, Luigi

PY - 2005/8

Y1 - 2005/8

N2 - There are conflicting reports regarding gliosarcomas. The goal of this study is to examine clinical, radiological, surgical and therapeutic aspects of 11 patients with gliosarcoma. Between 1993 and 2001, 11 patients with cerebral gliosarcoma were treated at our Institute. Ten patients underwent surgery and one patient had stereotactic biopsy. Four patients received whole brain radiotherapy with 60Co, five underwent radiotherapy with LINAC extended 2 cm beyond the edema margins. One patient refused any additional treatment after surgery and one patient was not treated postoperatively for poor clinical conditions (KPS 40). Chemotherapy (temozolomide) was administered to four patients. Four patients had a prevalence of sarcomatous component that corresponded to surgical and radiological aspects similar to meningioma while six patients showed a prevalence of gliomatous component and radiological and surgical aspects similar to those of glioblastomas. Surgical resection was total in six and subtotal in four patients. Patients with prevalent sarcomatous component showed median survival time more prolonged than patients with prevalent gliomatous component (71 ± 6 weeks vs. 63 ± 6; P =0.0417). Moreover, the survival rate differed in relation to the therapy: patients treated with multimodality therapy (surgery, radiotherapy and chemotherapy) had a longer survival time than patients treated in single or bimodality. Despite prognosis of gliosarcomas remains poor, a multidisciplinary approach (surgery, radiotherapy and chemotherapy) seems to be associated with slight more prolonged survival times.

AB - There are conflicting reports regarding gliosarcomas. The goal of this study is to examine clinical, radiological, surgical and therapeutic aspects of 11 patients with gliosarcoma. Between 1993 and 2001, 11 patients with cerebral gliosarcoma were treated at our Institute. Ten patients underwent surgery and one patient had stereotactic biopsy. Four patients received whole brain radiotherapy with 60Co, five underwent radiotherapy with LINAC extended 2 cm beyond the edema margins. One patient refused any additional treatment after surgery and one patient was not treated postoperatively for poor clinical conditions (KPS 40). Chemotherapy (temozolomide) was administered to four patients. Four patients had a prevalence of sarcomatous component that corresponded to surgical and radiological aspects similar to meningioma while six patients showed a prevalence of gliomatous component and radiological and surgical aspects similar to those of glioblastomas. Surgical resection was total in six and subtotal in four patients. Patients with prevalent sarcomatous component showed median survival time more prolonged than patients with prevalent gliomatous component (71 ± 6 weeks vs. 63 ± 6; P =0.0417). Moreover, the survival rate differed in relation to the therapy: patients treated with multimodality therapy (surgery, radiotherapy and chemotherapy) had a longer survival time than patients treated in single or bimodality. Despite prognosis of gliosarcomas remains poor, a multidisciplinary approach (surgery, radiotherapy and chemotherapy) seems to be associated with slight more prolonged survival times.

KW - Chemotherapy

KW - Gliosarcoma

KW - Prognosis

KW - Radiotherapy

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=23944485228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944485228&partnerID=8YFLogxK

U2 - 10.1007/s11060-004-5949-8

DO - 10.1007/s11060-004-5949-8

M3 - Article

C2 - 16078109

AN - SCOPUS:23944485228

VL - 74

SP - 59

EP - 63

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -